Sign inGet started

Seiter Christopher

Insider CIK 1774627 · TRVI Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TRVI Trevi Therapeutics, Inc. A Award deriv2021-02-172021-02-1980,000— $080,000SEC↗
TRVI Trevi Therapeutics, Inc. A Award deriv2020-02-132020-02-1865,000— $065,000SEC↗
TRVI Trevi Therapeutics, Inc. A Award deriv2019-06-032019-06-0550,000— $050,000SEC↗